Medroxyprogesterone Acetate Injectable Suspension Recalled Due to Cold Chain Failure
McKesson's Medroxyprogesterone Acetate Injectable Suspension is recalled due to cold chain failures from thunderstorms that may have compromised potency. The recall affects units distributed to medical facilities in Mississippi and Florida.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. However, the potential compromise of pharmaceutical potency due to temperature excursion during transit represents a risk-of-harm product where injury has not yet been reported, fitting the Score 3 criterion. The source uses cautious language and no actual potency loss has been confirmed.
Plain-English summary
Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL in single-dose vials is being recalled. The product is manufactured in India for Eugia US LLC of East Windsor, New Jersey, and distributed under NDC 55150-0330-01.
On April 2, 2025, a shipment experienced transit delays due to severe thunderstorms. The affected units were not delivered within the standard 48-hour timeframe and arrived on April 7 and 8, 2025. Because the products may not have been maintained at the recommended storage temperatures during transit, the safety, quality, identity, potency, and purity of the product may have been compromised.
The recalled lot is #1MP24042 with an expiration date of June 30, 2026. The product was distributed to medical facilities in Mississippi and Florida.
The recalled product
- Product
- Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Injectable Contraceptive
- Hazard
- cold-chain-failure
- potency-loss
- quality-compromise
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1MP24042
- Exp 6/30/26
Distribution
Distributed in 2 states:
- FL
- MS
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27